Last reviewed · How we verify
Topical treatments or phototherapy — Competitive Intelligence Brief
phase 3
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Topical treatments or phototherapy (Topical treatments or phototherapy) — Amgen. Phototherapy uses specific wavelengths of light to target and treat skin conditions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Topical treatments or phototherapy TARGET | Topical treatments or phototherapy | Amgen | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Topical treatments or phototherapy CI watch — RSS
- Topical treatments or phototherapy CI watch — Atom
- Topical treatments or phototherapy CI watch — JSON
- Topical treatments or phototherapy alone — RSS
Cite this brief
Drug Landscape (2026). Topical treatments or phototherapy — Competitive Intelligence Brief. https://druglandscape.com/ci/topical-treatments-or-phototherapy. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab